Vimarsana
Biggest News Aggregation in the World

Page 35 - Dave Fredrickson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Fredrickson Today - Breaking & Trending Today

AstraZeneca's Tagrisso gets broader U.S. FDA nod for lung cancer - Vimarsana News

AstraZeneca's Tagrisso gets broader U.S. FDA nod for lung cancer

Duluth, MN, USA / 710 AM 98.1 FM WDSM Dec 21, 2020 1:39 AM (Reuters) -AstraZeneca Plc said on Monday that the U.S. drug regulator had approved Tagrisso, the British drugmaker's top selling treatment for another type of lung cancer when diagnosed at an early stage, pushing its potential sales higher. The lung cancer drug has now been approved in the United States for adjuvant treatment of adults diagnosed early enough for the tumour to be surgically removed, and who have a mutation of the EGFR gene, AstraZeneca said. The approval by the U.S. Food and Drug Administration was based on late-stage...

Tagrisso approved in the US for the adjuvant treatment of patients... - Vimarsana News

Tagrisso approved in the US for the adjuvant treatment of patients...

AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent. Tagrisso is indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 L858R mutations as detected by an approved test. The approval was granted under the US Food and Drug Administration’s (FDA) Real-Time Oncology Review (RTOR) pilot program. Five other countries participated in a concurrent submission and review proc...